AJANTA PHARMA
Back to Balance Sheet
|
AJANTA PHARMA Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹996 Cr | ₹895 Cr | ₹1,139 Cr | ₹647 Cr | ₹839 Cr |
What is the latest Total Current Liabilities ratio of AJANTA PHARMA ?
Year | Total Current Liabilities |
---|---|
Mar2025 | ₹996 Cr |
Mar2024 | ₹895 Cr |
Mar2023 | ₹1,139 Cr |
Mar2022 | ₹647 Cr |
Mar2021 | ₹839 Cr |
How is Total Current Liabilities of AJANTA PHARMA Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹996 Cr | 11.27 | |
Mar2024 | ₹895 Cr | -21.42 | |
Mar2023 | ₹1,139 Cr | 75.98 | |
Mar2022 | ₹647 Cr | -22.82 | |
Mar2021 | ₹839 Cr | - |
Compare Total Current Liabilities of peers of AJANTA PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AJANTA PHARMA | ₹32,206.1 Cr | -0.4% | -4.5% | -24.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹387,792.0 Cr | 2.3% | -0.4% | -12.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,986.0 Cr | 0% | 1.1% | 10.7% | Stock Analytics | |
CIPLA | ₹127,124.0 Cr | 2.1% | 3.5% | -4.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹120,700.0 Cr | -1.2% | -1.7% | 4.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹109,868.0 Cr | 5.3% | 7.9% | -2% | Stock Analytics |
AJANTA PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AJANTA PHARMA | -0.4% |
-4.5% |
-24.9% |
SENSEX | 1.5% |
1.6% |
0.4% |
You may also like the below Video Courses